Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis

Published:2008-01-11 Issue:2 Volume:24 Page:497-505
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Reynolds Matthew W.¹,Shibata Atsuko²,Zhao Sean²,Jones Natalie¹,Fahrbach Kyle¹,Tim Goodnough Lawrence³

Affiliation:

1. United BioSource Corporation Medford, MAUSA

2. Amgen Inc. Thousand Oaks, CAUSA

3. Department of PathologyStanford University School of Medicine Stanford, CAUSA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079908X261050

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology;European Journal of Heart Failure;2024-08-28

2. Percutaneous transcatheter aspiration of pulmonary embolism leading to diagnosis of hepatocellular carcinoma tumor embolus and change in systemic chemotherapy;Acta Radiologica Open;2024-05-16

3. Unveiling the diagnostic enigma of D‐dimer testing in cancer patients: Current evidence and areas of application;European Journal of Clinical Investigation;2023-07-06

4. A case of pulmonary tumor embolism syndrome with thrombus in transit;Respiratory Medicine Case Reports;2023

5. The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism;International Journal of Cardiology;2023-01